Gupta Shalabh K.
SEC insider (Form 3/4/5 filer). CIK 0001864917. CEO at Unicycive Therapeutics, Inc. (UNCY). 3 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in MOUNTAIN VIEW, CA.
Companies Gupta Shalabh K. has filed insider reports for
- Unicycive Therapeutics, Inc. (UNCY): Director, Officer, CEO
Gupta Shalabh K.
CIK: 0001864917
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UNCY
Unicycive Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
762.2K shares- - May 14, 2026UNCY
Unicycive Therapeutics, Inc.
AwardDirectRestricted Stock Units
762.2K shares- - Jul 28, 2025UNCY
Unicycive Therapeutics, Inc.
AwardDirectStock Options
325K shares-
1-3 of 3 transactions